SY1.DE Stock Today, December 31: 2025 Revenue Below Early Targets
Symrise stock is in focus today as management signaled 2025 revenue growth below early targets, cooling near-term hopes while keeping long-term drivers intact. Recent trading has stayed range-bound, with valuation pressure after a tough year for MDAX defensives. We review the latest SY1.DE share price, key technical levels, and fundamentals to help German investors set expectations into the 2026 earnings season. Early planning matters as the fragrances and flavors market stabilizes and margin execution moves to the front seat.
SY1.DE price, valuation, and trend
Recent quotes show SY1.DE at €68.88, day range €68.48–€69.06, and 52-week range €64.70–€107.20. Market cap stands at about €9.63 billion. The stock trails its 50-day average of €71.12 and 200-day average of €85.14, reflecting a year of derating. After a long slide, the share is near technical support, with volumes below the 349,111 average.
At a P/E of 18.98 and price-to-sales of 1.92, Symrise stock trades below its multi-year averages but still at a premium to some specialty chemical peers, reflecting defensive cash flows. Price-to-book is 2.57 and dividend yield is roughly 1.75% with a 33% payout ratio. Investors will watch whether slower 2025 revenue growth resets expectations enough to re-rate margins.
RSI is 47.3, which is neutral. MACD histogram has turned slightly positive, while ADX at 29.4 signals a firm trend. Bollinger middle band sits near €68.49, with upper at €71.03. Average true range is €1.35, suggesting contained volatility. A sustained close above €71 could open €74–€76. Weakness below €68 risks a retest of €66 and the €64.70 52-week low.
Guidance reset and what to watch in 2025
Management now expects 2025 revenue growth, but below early targets, pointing to a measured start to the year. This follows months of sideways action and valuation compression in MDAX defensives. Local coverage has tracked sentiment and operations in Holzminden, offering context for near-term expectations source.
With the fragrances and flavors market normalizing, the focus shifts to pricing, mix, and costs. Gross margin near 40% provides a base, while cash generation improved last year. Investors will watch inventory turns and working capital discipline. A clean path to higher free cash flow could offset slower top-line growth and support a steadier multiple for Symrise stock.
Key demand markers include personal care, pet food, and beverage flavors. Stabilizing orders from Europe and North America would help, while Asia mix remains a swing factor. Local reports suggest constructive early trading days at times this year, echoing cautious optimism in Germany’s market press source. Earnings on 11 March 2026 will be a critical check-in.
Positioning within MDAX defensives
Among MDAX defensives, Symrise stock benefits from diversified end-markets and brand relationships. A composite rating shows B+ and a neutral stance, reflecting mixed valuation signals against strong returns metrics. Net debt to EBITDA sits near 2x, and the dividend track record remains intact. Investors looking for quality often weigh these against price momentum.
Key risks include input cost spikes, slower consumer staples demand, and currency. Interest coverage is subdued on recent figures, a point to monitor if rates stay higher for longer. Execution on Scent & Care and Taste, Nutrition & Health is vital. Any delay in margin recovery could extend the consolidation in the SY1.DE share price.
We prefer staged entries. Accumulate on dips near support if volumes stay light and momentum stabilizes. Consider partial profit-taking near €74–€76 into resistance. Use a stop policy below €64.70. For long-term holders, reinvest dividends and watch cash conversion, pricing discipline, and the fragrances and flavors market mix across regions.
Final Thoughts
Symrise stock sits at an inflection point. Management now aims for 2025 growth below early targets, which should reset expectations and put more weight on margins and cash flow. Valuation is no longer stretched, but momentum remains fragile. We suggest a patient, rules-based plan: scale in near support, respect stops under the 52-week low, and trim into strength around €74–€76. Track pricing, mix, and working capital to judge whether free cash flow trends can improve despite slower revenue. The 11 March 2026 earnings update will be the decisive catalyst. Until then, position size prudently and stay data-driven.
FAQs
It depends on time horizon. For traders, the setup is range-bound with resistance around €74–€76. For long-term investors, quality remains, but growth slowed. A phased entry near support with strict stops makes sense while waiting for margin and cash flow trends to firm up into March 2026.
Nearby support is around €68 and then €66, with the 52-week low at €64.70. On the upside, watch €71 as a trigger and €74–€76 as resistance. A close above €76 on rising volume would improve trend strength, while a break below €64.70 weakens the medium-term case.
Recent data show a P/E near 19, price-to-sales around 1.9, and price-to-book about 2.6. Dividend yield is roughly 1.75% with a payout near one-third of earnings. These levels are below multi-year averages, reflecting slower growth. Re-rating likely needs clear progress on margins and cash generation.
It remains a quality defensive with diversified demand in personal care, food, and pet nutrition. Compared with peers, it offers strong brand ties and steady cash flows. Near term, guidance cuts cap upside. Longer term, improved mix and cost control could restore confidence if the fragrances and flavors market stabilizes.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
